Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?

Alimentary pharmacology & therapeutics - 1 Mar 2014

Galmozzi E, Viganò M, Lampertico P

Abstract excerpt

BACKGROUND: Interferon lambda 3 (IFN-λ3) polymorphisms are the strongest genetic predictor of outcome of hepatitis C virus infection and of response to Pegylated interferon (PegIFN)-based therapy. Whether this holds true for hepatitis B virus (HBV) infection is matter of controversy. AIM: To review the association between host genomics and spontaneous or interferon-induced clearance of HBV with specific reference...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Hepatitis B

Share to Hepatitis B e Antigens

Share to Hepatitis B virus

Share to Interferons

Share to Interleukins

Source

Identifiers

PMID: 24461198
DOI: 10.1111/apt.12631

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?PMID 24461198Read ↗

The impact of interferon lambda 3 gene polymorphism on natural course and treatment of hepatitis C.Semantic proximity Read ↗

The role of genetic markers in hepatitis C virus therapy: a major step for individualized care.Semantic proximity Read ↗

Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions.Semantic proximity Read ↗

Interferon lambda-3 polymorphism and response to pegylated interferon in patients with hepatitis D.Semantic proximity Read ↗

No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B.Semantic proximity Read ↗

Interferon lambdas: the next cytokine storm.Semantic proximity Read ↗

Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha.Semantic proximity Read ↗

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.Semantic proximity Read ↗

Host - hepatitis C viral interactions: The role of genetics.Semantic proximity Read ↗

Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.Semantic proximity Read ↗

Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.Semantic proximity Read ↗

Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.